Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 2462129)

Published in Lab Invest on December 01, 1988

Authors

J Peltonen1, S Jaakkola, M Lebwohl, S Renvall, L Risteli, I Virtanen, J Uitto

Author Affiliations

1: Department of Dermatology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.

Articles citing this

Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev (2001) 4.68

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Clin Invest (2000) 1.56

Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest (1989) 1.52

Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol Cell Biol (1997) 1.33

Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol (2001) 1.30

Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol (1990) 1.28

The pathoetiology of neurofibromatosis 1. Am J Pathol (2011) 1.13

Atrial myxoma: a tumour in search of its origins. Br Heart J (1992) 1.11

The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol (1999) 1.06

The development of cutaneous neurofibromas. Am J Pathol (2011) 1.04

Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures. J Clin Invest (1989) 0.97

Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development (1995) 0.97

Oral soft tissue alterations in patients with neurofibromatosis. Clin Oral Investig (2011) 0.92

Collagen gene expression by cultured human skin fibroblasts. Abundant steady-state levels of type VI procollagen messenger RNAs. J Clin Invest (1989) 0.87

Barriers of the peripheral nerve. Tissue Barriers (2013) 0.87

Perineurial cells coexpress genes encoding interstitial collagens and basement membrane zone components. J Cell Biol (1989) 0.86

Plasticity of integrin expression by nerve-derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro. J Clin Invest (1991) 0.84

The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Oncogene (2017) 0.75

Comparative study of CO2- and Er:YAG laser ablation of multiple cutaneous neurofibromas in von Recklinghausen's disease. Lasers Med Sci (2013) 0.75

Articles by these authors

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol (2001) 3.92

Subcellular compartmentalization of saccharide moieties in cultured normal and malignant cells. J Cell Biol (1980) 3.92

Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29

Expression of Snail protein in tumor-stroma interface. Oncogene (2006) 2.68

Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem (1990) 2.51

Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins. J Cell Biol (1980) 2.50

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44

Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol (1990) 2.39

Intermediate filaments anchor the nuclei in nuclear monolayers of cultured human fibroblasts. Nature (1978) 2.28

Expression of intermediate filaments in cultured cells. J Cell Sci (1981) 2.25

Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23

The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21

Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09

Sterility of refrigerated injectable collagen syringes after injection of patient. J Am Acad Dermatol (1992) 2.05

Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01

Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A (2000) 1.97

Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97

Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology (1994) 1.96

Comparison of nerve cell and nerve cell plus Schwann cell cultures, with particular emphasis on basal lamina and collagen formation. J Cell Biol (1980) 1.96

Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr (1998) 1.94

Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94

Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90

The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87

Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82

Human smooth muscle autoantibodies reacting with intermediate (100 A) filaments. Nature (1977) 1.82

Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78

Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol (2002) 1.75

Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet (1997) 1.75

Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75

Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73

Connective tissue nevi of the skin. Clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type. J Am Acad Dermatol (1980) 1.71

Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet (1995) 1.71

Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol (1999) 1.70

Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol (1995) 1.69

Human elastin gene: new evidence for localization to the long arm of chromosome 7. Am J Hum Genet (1991) 1.69

Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA. J Biol Chem (1993) 1.69

Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol (1999) 1.67

Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J Immunol (1983) 1.67

Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66

Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet (1994) 1.65

Ultrastructure of human natural killer cells: nature of the cytolytic contacts in relation to cellular secretion. J Immunol (1982) 1.65

The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol (1990) 1.64

Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63

Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci (1999) 1.61

Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci (1987) 1.60

A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics (1994) 1.59

Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell (1997) 1.57

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57

Increased collagen cross-linkages in experimental diabetes: reversal by beta-aminopropionitrile and D-penicillamine. Diabetes (1980) 1.56

Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56

Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56

Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem (1991) 1.55

trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci (2001) 1.54

A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet (1993) 1.53

Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol (1998) 1.53

Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J Histochem Cytochem (1987) 1.53

Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest (1989) 1.52

An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem (1996) 1.52

Duration of remission of psoriasis therapies. J Am Acad Dermatol (1999) 1.51

Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol Chem (1994) 1.51

Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene (2001) 1.51

Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome. Arch Dermatol (1997) 1.48

Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading. Mol Cell Biol (1995) 1.47

A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet (1996) 1.47

Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem (1991) 1.46

Synovial sarcoma--a misnomer. Am J Pathol (1984) 1.46

The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med (1992) 1.46

Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45

Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45

Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene. Am J Hum Genet (1989) 1.44

Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol (1983) 1.44

Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med (2000) 1.43

The detection of human antibodies against cytoskeletal components. J Immunol Methods (1984) 1.43

Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics (1994) 1.43

Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42

New cutaneous manifestations of systemic diseases. Am Fam Physician (1995) 1.42

Further evaluation of the significance of urinary hydroxyproline determinations in the diagnosis of thyroid disorders. Clin Chim Acta (1968) 1.41

Antibodies to cytoplasmic intermediate filaments in rheumatic diseases. J Rheumatol (1983) 1.41

Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol (1998) 1.40

Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40

Characterization of the complete human elastin gene. Delineation of unusual features in the 5'-flanking region. J Biol Chem (1989) 1.40

The cytotoxic activity of human natural killer cells requires an intact secretory apparatus. Cell Immunol (1981) 1.40

A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl) (2000) 1.39

Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med (1997) 1.39

Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest (1980) 1.39

Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane. J Rheumatol (2001) 1.39

Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol (1998) 1.39

Fibrillar protein deposits with tubular substructure in a systemic disease beginning as cutis laxa. Arch Dermatol (1993) 1.38

Atopic dermatitis. Lancet (1998) 1.37

Laminin. Methods Enzymol (1982) 1.37

The p36 substrate of tyrosine-specific protein kinases co-localizes with non-erythrocyte alpha-spectrin antigen, p230, in surface lamina of cultured fibroblasts. EMBO J (1983) 1.36

Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. J Biol Chem (1995) 1.35

Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast. J Submicrosc Cytol Pathol (1993) 1.35

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer (1992) 1.34

Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. Am J Pathol (1991) 1.34

Connective tissue biochemistry of the aging dermis. Age-related alterations in collagen and elastin. Dermatol Clin (1986) 1.34

Formation of interchain disulfide bonds and helical structure during biosynthesis of procollagen by embryonic tendon cells. Biochemistry (1974) 1.33

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer (1998) 1.32